{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:30:50Z","timestamp":1791307850461,"version":"4.3.1"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T00:00:00Z","timestamp":1355097600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0051661","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T20:34:21Z","timestamp":1355258061000},"page":"e51661","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cellular and Molecular Mechanisms Underlie the Anti-Tumor Activities Exerted by Walterinnesia aegyptia Venom Combined with Silica Nanoparticles against Multiple Myeloma Cancer Cell Types"],"prefix":"10.1371","volume":"7","author":[{"given":"Gamal","family":"Badr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed K.","family":"Al-Sadoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa A.","family":"Abdel-Maksoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny M.","family":"Rabah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"El-Toni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta15410","article-title":"The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation","volume":"15","author":"J Picot","year":"2011","journal-title":"Health Technol Assess"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"712613","DOI":"10.1155\/2012\/712613","article-title":"Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma","volume":"2012","author":"SA Tuchman","year":"2012","journal-title":"Adv Hematol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0065-2776(01)78002-9","article-title":"Chemokines in immunity","volume":"78","author":"O Yoshie","year":"2001","journal-title":"Adv Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.exphem.2006.06.017","article-title":"Chemokines in multiple myeloma","volume":"34","author":"R Aggarwal","year":"2006","journal-title":"Exp Hematol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1185\/030079903125002216","article-title":"Chemokines key players in cancer","volume":"19","author":"M Arya","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.leu.2402717","article-title":"Expression and function of chemokine receptors in human multiple myeloma","volume":"17","author":"C Moller","year":"2003","journal-title":"Leukemia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11912-009-0019-1","article-title":"The chemokine receptors CXCR4 and CXCR3 in cancer","volume":"11","author":"AM Fulton","year":"2009","journal-title":"Curr Oncol Rep"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2006-07-035857","article-title":"Mechanisms of regulation of CXCR4\/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma","volume":"109","author":"Y Alsayed","year":"2007","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/156800912802429300","article-title":"Molecular targets for the treatment of Multiple myeloma","volume":"12","author":"M Rossi","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/CAD.0b013e32835679b8","article-title":"Concurrent blockade of NF\u03baB and AKT pathways potentiates cisplatin\u2019s antitumor activity in vivo","volume":"23","author":"H Sun","year":"2012","journal-title":"Anticancer Drugs"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e39870","DOI":"10.1371\/journal.pone.0039870","article-title":"Histone deacetylase inhibitors facilitate dihydroartemisinin-induced apoptosis in liver cancer in vitro and in vivo","volume":"7","author":"CZ Zhang","year":"2012","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e23741","DOI":"10.1371\/journal.pone.0023741","article-title":"Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis","volume":"6","author":"G Badr","year":"2011","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e39968","DOI":"10.1371\/journal.pone.0039968","article-title":"AF1q: A Novel Mediator of Basal and 4-HPR-Induced Apoptosis in Ovarian Cancer Cells","volume":"7","author":"P Tiberio","year":"2012","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s004410000196","article-title":"Apoptosis in prostate carcinogenesis. A growth regulator and a therapeutic target","volume":"301","author":"EM Bruckheimer","year":"2000","journal-title":"Cell Tissue Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000085404","article-title":"Apoptosis a brief review","volume":"3","author":"A Zhang","year":"2004","journal-title":"Neuroembryology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"838916","DOI":"10.1100\/2012\/838916","article-title":"The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: BCL-2L12 and beyond","volume":"2012","author":"FM Kouri","year":"2012","journal-title":"Scientific World Journal"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death","volume":"74","author":"ZN Oltvai","year":"1993","journal-title":"Cell"},{"key":"ref18","first-page":"1409","article-title":"Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer","volume":"5","author":"Q Gao","year":"2012","journal-title":"Mol Med Report"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/107327481101800406","article-title":"Advances in the autologous and allogeneic transplantation strategies for multiple myeloma","volume":"18","author":"T Nishihori","year":"2011","journal-title":"Cancer Control"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cancergencyto.2006.01.002","article-title":"Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome","volume":"167","author":"Y Ishii","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1200\/JCO.2004.03.086","article-title":"Antioxidants and cancer therapy: a systematic review","volume":"22","author":"EJ Ladas","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref22","first-page":"73","article-title":"Sansalvamide induces pancreatic cancer growth arrest through changes in the cell cycle","volume":"30","author":"MJ Heiferman","year":"2010","journal-title":"Anticancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e40152","DOI":"10.1371\/journal.pone.0040152","article-title":"An Aqueous Extract of Fagonia cretica Induces DNA Damage, Cell Cycle Arrest and Apoptosis in Breast Cancer Cells via FOXO3a and p53 Expression","volume":"7","author":"M Lam","year":"2012","journal-title":"PLoS One"},{"key":"ref24","first-page":"183","article-title":"Novel Snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model","volume":"31","author":"S Francis","year":"2001","journal-title":"Haemostasis"},{"key":"ref25","first-page":"11","article-title":"Walterinnesia aegyptia venom combined with silica nanoparticles enhances the functioning of normal lymphocytes through PI3K\/AKT, NF\u03baB and ERK signaling","volume":"2012","author":"G Badr","year":"2012","journal-title":"Lipids Health Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1159\/000341446","article-title":"Induction of Apoptosis and Growth Arrest in Human Breast Carcinoma Cells by a Snake (Walterinnesia aegyptia) Venom Combined With Silica Nanoparticles: Crosstalk Between Bcl2 and Caspase 3","volume":"30","author":"MK Al-Sadoon","year":"2012","journal-title":"Cell Physiol Biochem"},{"key":"ref27","first-page":"675","article-title":"Inhibitory effect of snake venom toxin from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth: induction of apoptosis through inactivation of nuclear factor kappa B. Mol Cancer Ther","volume":"6","author":"DJ Son","year":"2007"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s000180300002","article-title":"Colloidal drug carriers: achievements and perspectives","volume":"60","author":"G Barratt","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4049\/jimmunol.175.1.302","article-title":"HIV type 1 glycoprotein 120 inhibits human B cell chemotaxis to CXC chemokine ligand (CXCL) 12, CC chemokine ligand (CCL) 20, and CCL21","volume":"175","author":"G Badr","year":"2005","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"8916","DOI":"10.1021\/ja051113r","article-title":"Fabrication of uniform magnetic nanocomposite spheres with a magnetic core\/mesoporous silica shell structure","volume":"127","author":"W Zhao","year":"2005","journal-title":"J Am Chem Soc"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcis.2012.04.006","article-title":"Synthesis of double mesoporous core-shell silica spheres with tunable core porosity and their drug release and cancer cell apoptosis properties","volume":"378","author":"AM El-Toni","year":"2012","journal-title":"J Colloid Interface Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/01.cji.0000210079.52554.c3","article-title":"The Fc portion of UV3, an anti-CD54 monoclonal antibody, is critical for its antitumor activity in SCID mice with human multiple myeloma or lymphoma cell lines","volume":"29","author":"EJ Coleman","year":"2006","journal-title":"J Immunother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/1471-2407-12-228","article-title":"Snake venom toxin from Vipera lebetina turanica induces apoptosis in colon cancer cells via upregulation of ROS- and JNK-mediated death receptor expression","volume":"12(1)","author":"MH Park","year":"2012","journal-title":"BMC Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s12272-012-0512-1","article-title":"Cell growth inhibition and induction of apoptosis by snake venom toxin in ovarian cancer cell via inactivation of nuclear factor \u03baB and signal transducer and activator of transcription 3","volume":"35","author":"JK Song","year":"2012","journal-title":"Arch Pharm Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1517\/14712598.2012.664128","article-title":"Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?","volume":"12","author":"K J\u00f6hrer","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1182\/blood-2008-10-186668","article-title":"CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy","volume":"113","author":"AK Azab","year":"2009","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"24515","DOI":"10.1074\/jbc.M200889200","article-title":"A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40\u20134C are weak partial agonists","volume":"277","author":"WB Zhang","year":"2002","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1040-8428(01)00202-5","article-title":"Peripheral blood stem cell mobilization. A role for CXC chemokines","volume":"43","author":"LM Pelus","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood-2004-12-4942","article-title":"ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow","volume":"106","author":"L Yang","year":"2005","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.toxicon.2007.07.016","article-title":"Effect of RGD disintegrins on melanoma cell growth and metastasis: involvement of the actin cytoskeleton, FAK and c-Fos","volume":"50","author":"IB Oliva","year":"2007","journal-title":"Toxicon"},{"key":"ref41","first-page":"605","article-title":"The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM model","volume":"91","author":"E Menu","year":"2006","journal-title":"Haematologica"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1158\/0008-5472.CAN-11-3240","article-title":"Pim kinase inhibitors sensitize prostate cancer cells to apoptosis triggered by Bcl-2 family inhibitor ABT-737","volume":"72","author":"JH Song","year":"2012","journal-title":"Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s12272-009-2106-0","article-title":"Snake venom toxin inhibits cell growth through induction of apoptosis in neuroblastoma cells","volume":"32","author":"MH Park","year":"2009","journal-title":"Arch Pharm Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1126\/science.281.5381.1312","article-title":"Caspases: enemies within","volume":"281","author":"NA Thornberry","year":"1998","journal-title":"Science"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1158\/1535-7163.MCT-06-0681","article-title":"Loss of mitochondrial membrane potential is inhibited by bombesin in etoposide-induced apoptosis in PC-3 prostate carcinoma cells","volume":"6","author":"M Salido","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Kolluru LP, Rizvi SA, D\u2019Souza M, D\u2019Souza MJ (2012) Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting. J Drug Target. 2012 Oct 5.","DOI":"10.3109\/1061186X.2012.729214"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","article-title":"Nanocarriers\u2019 entry into the cell: relevance to drug delivery","volume":"66","author":"H Hillaireau","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/138920010791110827","article-title":"Nanoparticles for tumor targeted therapies and their pharmacokinetics","volume":"11","author":"J Wang","year":"2010","journal-title":"Curr Drug Metab"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.nantod.2012.06.010","article-title":"Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers","volume":"7","author":"F Haque","year":"2012","journal-title":"Nano Today"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2009.01.018","article-title":"Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles","volume":"135","author":"HY Nam","year":"2009","journal-title":"J Control Release"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1021\/ar2000138","article-title":"In vivo targeted delivery of nanoparticles for theranosis","volume":"44","author":"H Koo","year":"2011","journal-title":"Acc Chem Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1016\/j.biomaterials.2011.01.054","article-title":"Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles","volume":"32","author":"SM Lim","year":"2011","journal-title":"Biomaterials"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1166\/jbn.2012.1465","article-title":"Temperature-sensitive polymer-coated magnetic nanoparticles as a potential drug delivery system for targeted therapy of thyroid cancer","volume":"8","author":"B Koppolu","year":"2012","journal-title":"J Biomed Nanotechnol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.2147\/IJN.S35140","article-title":"Biocompatibility of magnetic Fe(3)O(4) nanoparticles and their cytotoxic effect on MCF-7 cells","volume":"7","author":"D Chen","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1021\/bc800206r","article-title":"Cellular uptake and intracellular pathways of PLL-g-PEG-DNA nanoparticles","volume":"19","author":"T L\u00fchmann","year":"2008","journal-title":"Bioconjug Chem"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.2147\/IJN.S30726","article-title":"Liposomes and nanotechnology in drug development: focus on oncotargets","volume":"7","author":"T Kozako","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e24438","DOI":"10.1371\/journal.pone.0024438","article-title":"Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines","volume":"6","author":"T Dos Santos","year":"2011","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0051661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T01:19:17Z","timestamp":1643851157000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0051661"}},"subtitle":[],"editor":[{"given":"Jin Q.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,10]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0051661","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,10]]}}}